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Background: The objective of the present study was to determine the phytochemical content and the protective
effect of red grape skin extract (RGSE) against fructose-mediated protein oxidation. In addition, RGSE was screened
for its potential as an antioxidant using various in vitro models.
Methods: Antioxidant activity was measured by 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl radical scavenging
activity, superoxide radical scavenging activity, trolox equivalent antioxidant capacity, ferric reducing antioxidant
power (FRAP), ferrous ion chelating power. The total phenols content was measured by Folin–Ciocalteu assay, the
flavonoids content by the AlCl3 colorimetric method. Antiglycation activity was determined using the formation of
AGE fluorescence intensity, Nε-(carboxymethyl)lysine, and the level of fructosamine. The protein oxidation was
examined using the level of protein carbonyl content and thiol group.
Results: The results showed that the content of total phenolics, flavonoids and total anthocyanins in RGSE was
246.3 ± 0.9 mg gallic acid equivalent/g dried extract, 215.9 ± 1.3 mg catechin equivalent/g dried extract, and
36.7 ± 0.8 mg cyanidin-3-glucoside equivalent/g dried extract, respectively. In the DPPH radical scavenging
activity, hydroxyl radical scavenging activity, and superoxide radical scavenging activity, RGSE had the IC50 values
of 0.03 ± 0.01 mg/ml, 5.40 ± 0.01 mg/ml, and 0.58 ± 0.01 mg/ml, respectively. In addition, RGSE had trolox
equivalent antioxidant capacity assay (395.65 ± 1.61 mg trolox equivalent/g dried extract), ferric reducing
antioxidant power (114.24 ± 0.03 mM FeSO4/g dried extract), and ferrous ion chelating power (3,474.05 ± 5.55 mg
EDTA/g dried extract), respectively. The results showed that RGSE at different concentrations (0.031–0.500 mg/ml)
has significantly inhibited the formation of AGEs in terms of the fluorescence intensity of glycated BSA during
4 weeks of study. The RGSE markedly decreased the level of fructosamine, which is directly associated with
the reduction of AGE formation and Nε-(carboxymethyl)lysine (CML). The results demonstrated the significant effect
of RGSE on preventing protein oxidative damages, including effects on the thiol and protein carbonyl oxidation.
Conclusions: The present study revealed that RGSE would exert beneficial effects by virtue of its antioxidants and
antiglycation. The findings could provide a new insight into the naturally occurring antiglycation properties of RGSE
for preventing AGE-mediated diabetic complication.
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Protein glycation is a non-enzymatic reaction that initi-
ates from a complex cascade of several reactions be-
tween reducing sugar and free amino group, resulting in
the formation of a reversible structure called a Schiff ’s
base [1]. Then, it undergoes rearrangements to the
Amadori products that induce further oxidation, gen-
erating dicarbonyl compounds to form cross-linking
fluorescent (e.g., pentosidine) and non-fluorescent ad-
ducts (e.g., CML) called advanced glycation end products
(AGEs). AGEs, the unstable and irreversible product of
glycation process, can react with other free amino group
and lead to protein modification such as alternative pro-
tein half-life, immune system, and enzyme function, lead-
ing to physiopathological changes [2]. Many studies have
revealed a vital role for protein glycation in the patho-
genesis of age-related diseases, such as diabetes, athero-
sclerosis, end-stage renal disease, and neurodegenerative
disease [2]. There has recently been much interest in
using antiglycation for alleviating diabetic complications
[3]. Aminoguanidine (AG), a hydrazine derivative, acts by
trapping reactive carbonyl intermediates and blocking
formation of Schiff base or AGEs [4]. However, it has
shown serious side effects in type 2 diabetic nephropathy
such as flu-like symptoms, gastrointestinal problems, and
anemia [5]. Therefore, much effort has been extended in
search of dietary plants and fruits that effectively inhibit
AGE formation.
Red grape, Vitis vinifera is one of the most popular
and widely cultivated fruits in the world. The skin of the
red grape contains many active components, including
flavonoids, anthocyanins, procyanidins, and the stilbene
derivatives resveratrol. The major pharmacological prop-
erties of red grape skin and its constituents are anti-
cancer [6], anti-diabetes [7], anti-obesity [8], anti-platelet
aggregation [9], and anti-hypertension [10]. The prelim-
inary observations indicate that grape skin and seed in-
hibit protein glycation in bovine serum albumin [11,12].
Anthocyanins are pigments, and mainly exist in grape
skins. It has been shown that grape skin is able to act as
a natural anthocyanin against mammalian intestinal α-
glucosidase and pancreatic α-amylase [13-16]. However,
there are no studies supporting the ability of grape skin
in the prevention of diabetic complications by inhibiting
the formation of AGEs, the level of fructosamine, pro-
tein oxidation, and non-fluorescent adducts. Therefore,
it was interesting to investigate the effects of the RGSE
against fructose-mediated non-enzymatic glycation and
oxidation-dependent damages to BSA. In addition, the
phytochemical contents and bioactivity of RGSE related
to antioxidants including 1,1-diphenyl-2-pireyhydrazyl
(DPPH) radical scavenging activity, trolox equivalent
antioxidant capacity assay (TEAC), ferric reducing anti-
oxidant power (FRAP) assay, hydroxyl radical scavengingactivity (HRSA), and superoxide radical scavenging activity
(SRSA), and metal chelating activity were also evaluated.
Methods
Chemicals
Bovine serum albumin (BSA), 2,2-diphenyl-1-picrylhydrazyl
(DPPH), 2,2-azinobis3-ethylbenzothiazoline-6-sulfonic
acid (Trolox), 2,4,6- tripyridyl-S-triazine (TPTZ), iron sul-
fate (FeSO4), xanthine, xanthine oxidase, 5,5′-dithiobisnitro
benzoic acid (DTNB), nitroblue tetrazolium (NBT), 1-
deoxy-1-morpholinofructose (DMF), 2,4-dinitrophenyl-
hydrazine (DNPH), and L-cysteine were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). Fructose,
Folin–Ciocalteu’s phenol reagent, and gallic acid were
purchased from Fluka (St. Louis, MO, USA). Nε-
(carboxymethyl) lysine (CML) test kit was purchased from
Cell Biolabs Inc. (U.S.A). The dried powder of red grape
skin extract (RGSE) (article no. 825F) was obtained from
Breko GmbH Co. (Bremen, Germany).
Phytochemical analysis
The RGSE (1 mg) was dissolved in distilled water (1 ml).
The total polyphenolic and flavonoid content in RGSE
was determined using Folin–Ciocalteu’s phenol reagent
and aluminum chloride colorimetric method, respect-
ively [12]. The total anthocyanin content in RGSE was
determined using pH differential method [17]. The total
polyphenolic, total flavonoid, and total anthocyanin con-
tent were expressed as mg gallic acid equivalent/g dried
extract, mg catechin equivalent/g dried extract, and mg
cyanidin-3-glucoside equivalent/g dried extract, respect-
ively (n = 3).
DPPH radical scavenging activity
RGSE was dissolved in phosphate buffered saline (PBS),
pH 7.4. Antioxidant capacity was measured using the
DPPH assay as described by a previous method [18].
Briefly, 100 μl of the solution containing RGSE dissolved
in PBS (0.0125–0.100 mg/ml) was added to 100 μl of a
DPPH solution (0.2 mM in ethanol) and incubated for
30 min at room temperature. The decrease in the so-
lution absorbance was measured at 515 nm. The IC50
value was calculated from the plotted graph of % DPPH
scavenging ability against the concentrations of the
samples. Ascorbic acid was used as a positive control
for this study.
Trolox equivalent antioxidant capacity assay
Trolox equivalent antioxidant capacity assay (TEAC) of
each sample was determined according to a method de-
scribed [19]. The ABTS · + was generated by persulfate
oxidation of ABTS by incubation at room temperature for
at least 16 hours in darkness. ABTSº+ solution was diluted
with phosphate buffer solution to absorbance values of
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500 μl of the solution containing RGSE dissolved in PBS
was added with 990 μl of ABTS · + solution. The decrease
in the absorbance was measured at 734 nm after 6 min.
Trolox was used as a positive control for this study. TEAC
value was calculated from a standard curve by using trolox.
TEAC value was expressed as mg of trolox equivalents per
gram of dried extract.
Ferric reducing antioxidant power (FRAP)
Ferric reducing antioxidant power (FRAP) was measured
according to a previous method with slight modifica-
tions [20]. Briefly, FRAP solution was mixed with 10 ml
of 0.3 M sodium acetate buffer solution (pH 3.6), 1 ml
of 10 mM 2,4,6- tripyridyl-S-triazine (TPTZ) in 40 mM
HCl, and 1 ml of 20 mM FeCl3. The solution containing
RGSE dissolved in PBS (0.2 ml) was added with 1.8 ml of
FRAP solution as oxidizing reagent and incubated for
30 min at room temperature. The increase in the solution
absorbance was measured at 593 nm. FRAP value was
calculated from a standard curve by using FeSO4. FRAP
value was expressed as mM of FeSO4 equivalents per
gram of dried extract.
Hydroxyl radical scavenging activity
Hydroxyl radical scavenging activity (HRSA) was mea-
sured by a previous method with minor modifications
[21]. The reaction mixture was done by adding 33 μl of
17 mM 2-deoxy2-ribose, 33 μl of the solution containing
RGSE dissolved in PBS (0.5–30 mg/ml), 33 μl of 1.2 mM
EDTA, 67 μl of 0.3 mM FeCl3, 33 μl of 34 mM hydrogen
peroxide (H2O2), and 67 μl of 0.6 mM ascorbic acid.
The reaction was performed at 37°C for 1 h. Thereafter,
333 μl of 1% (w/v) thiobarbituric acid (TBA) and 333 μl
of 2.8% (w/v) trichloroacetic acid (TCA) were added to
the mixture and were incubated at 100°C for 15 min.
After cooling, the absorbance was measured at 532 nm
against a blank containing deoxyribose and buffer. The
IC50 value was calculated from the plotted graph of % rad-
ical scavenging against the concentrations of the samples.
Trolox was used as a positive control for this study.
Superoxide radical scavenging activity
The measurement of superoxide radical scavenging ac-
tivity (SRSA) was done according to a previous method
with slight modifications [22]. In brief, 50 μl of the
solution containing RGSE dissolved in PBS (0.125–
5.00 mg/ml), 500 μl of 0.30 mM xanthine, 250 μl of
0.15 mM NBT, 250 μl of 0.60 mM EDTA, and 50 μl
of xanthine oxidase (0.05 unit/ml) were mixed and
placed in the wells of a microplate. After incubation
for 40 min at 37°C, the absorbance was measured at
560 nm. The IC50 value was calculated from the plotted
graph of %radical scavenging against the concentrationsof the samples. Trolox was used as a positive control for
this study.
Ferrous ion chelating power
Ferrous ion chelating power (FICP) was measured by 2,2′-
bipyridyl competing assay according to a previous study
with slight modifications [23]. In short, 0.25 ml of FeSO4
solution (1 mM) and an equal volume of the solution
containing RGSE dissolved in PBS were mixed and 1 ml of
0.1 M Tris–HCl buffer (pH 7.4) and 1 ml of 2,2′-bipyridyl
solution (0.1% in 0.2 M HCl) were added to the mixture,
together with 0.4 ml of 10% (w/v) hydroxylamine-HCl and
1.5 ml of ethanol. After filling the reaction mixture up to
5 ml with distilled water, the absorbance of the solution
was measured at 562 nm. FICP value was calculated from a
standard curve by using EDTA. FICP value was expressed
as mg of EDTA equivalents per gram of dried extract.
In vitro glycation of bovine serum albumin
The glycated BSA formation was undertaken in accordance
with a previous method [24]. Briefly, BSA (10 mg/ml) was
incubated with 1.1 M fructose in 0.1 M phosphate
buffered-saline (PBS), pH 7.4 containing 0.02% sodium
azide in darkness at 37°C for 1, 2, 3, and 4 weeks. Before
incubation, the solution containing RGSE dissolved in
PBS (0.031–0.500 mg/ml) was added to the mixtures.
The glycated BSA formation was determined using fluor-
escent intensity at an excitation wavelength 355 nm and
emission wavelength 460 nm. Aminoguanidine (AG) was
used as a positive control for this study.
Determination of Fructosamine
After 1, 2, 3, and 4 weeks of incubation, the concentra-
tion of fructosamine, the Amadori product, was mea-
sured by NBT assay [24]. Briefly, glycated BSA (10 μl)
was incubated with 90 μl of 0.5 mM NBT in 0.1 M car-
bonate buffer, pH 10.4 at 37°C. The absorbance was mea-
sured at 530 nm at 10 and 15 min time points. The
concentration of fructosamine was calculated compared to
1-deoxy-1-morpholino-fructose (1-DMF) as the standard.
Determination of protein carbonyl content
After 1, 2, 3, and 4 weeks of incubation, the carbonyl group
in glycated BSA, a marker for protein oxidative damage,
was assayed according to a previous method of Levine and
colleagues with minor modifications [24]. Briefly, 800 μl of
10 mM DNPH in 2.5 M HCl was added to 200 μl of
glycated samples. After 1 h incubation in the dark, 1 ml of
20% (w/v) TCA was used for protein precipitation (5 min
on ice) and then centrifuged at 10,000 g for 10 min at 4°C.
The protein pellet was washed with 500 μl of ethanol/ethyl
acetate (1:1) mixture 3 times and resuspended in 500 μl
of 6 M guanidine hydrochloride. The absorbance was
measured at 370 nm. The carbonyl content of each sample
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DNPH (ε = 22,000 M-1cm-1). The results were expressed as
nmol carbonyl/mg protein.
Determination of thiol group
After 1, 2, 3, and 4 weeks of incubation, the free thiols
in glycated samples were measured by Ellman’s assay
with minor modifications [24]. Briefly, 70 μl of glycated
samples were incubated with 130 μl of 5 mM DTNB in
0.1 M PBS, pH 7.4 at 25°C for 15 min. The absorbance
of samples was measured at 410 nm. The concentration
of free thiols was calculated from L-cysteine standard
and expressed as nmol/mg protein.
Determination of Nε-(carboxymethyl) lysine
After 4 weeks of incubation, Nε-(carboxymethyl) lysine
(CML), a major antigenic AGE structure, was determined
using enzyme linked immunosorbant assay (ELISA) kit.
According to the manufacturer’s protocol, the glycated
samples were diluted to final concentration of 1 μg/ml
(10,000-fold dilution) before used in the assay. Each diluted
sample (100 μl) was incubated in the 96-well protein bind-
ing plate at 37°C for at least 2 h. After washing with PBS,
an assay diluent was added and further incubated for 2 h at
room temperature on an orbital shaker. Three washes with
wash buffer were needed before incubating for 1 h each
with anti-CML antibody and with secondary antibody-
HRP conjugate. The substrate solution (100 μl) was added
for 20 min before adding stop solution in an equal volume.
The absorbance of samples was measured immediately at
450 nm and compared with the absorbance of CML-BSA
standard providing in the assay kit.
Statistical analysis
Data were presented as mean ± standard error of mean
(S.E.M) for N = 3. Data were analyzed using one-way
analysis of variance (ANOVA) and Tukey’s HSD test with
p < 0.05 were considered significant.
Results
Phytochemical analysis of RGSE
Our determination revealed that the content of total
phenolic compounds in RGSE was 246.3 ± 0.9 mg gallicTable 1 Antioxidant activity of RGSE including DPPH radical s
DPPH TEAC FRAP
RGSE 0.03 ± 0.01 395.65 ± 1.61 114.24
Ascorbic acid 0.01 ± 0.01 - -
Trolox - - -
Data are expressed as mean ± S.E.M, n = 3. DPPH radical scavenging activity, Hydrox
activity (SRSA) are expressed as the IC50 value (mg/ml). TEAC, FRAP, and FICP are ex
mg EDTA/gram dried extract, respectively.acid equivalent/g dried extract. In the meanwhile, the
content of total flavonoids in RGSE was 215.9 ± 1.3 mg
catechin equivalent/g dried extract. In addition, the
content of total anthocyanins in RGSE was determined
to be 36.7 ± 0.8 mg cyanidin-3-glucoside equivalent/g
dried extract.
Antioxidant activity of RGSE
The effects of RGSE on different antioxidant capacities
are shown in Table 1. On the DPPH assay, RGSE had
significant radical scavenging activity with increasing
concentration in the range of 0.0125–0.1000 mg/ml. The
IC50 values of RGSE and ascorbic acid were found to be
0.03 ± 0.01 mg/ml and 0.01 ± 0.01 mg/ml, respectively.
The results showed that RGSE had 3.0-times less po-
tency than ascorbic acid. According to the results from
TEAC, RGSE had antioxidant activity of 395.65 ± 1.61 mg
trolox equivalent/g dried extract. FRAP assay determines
the reducing ability of an antioxidant reacting with a ferric
tripyridyltriazine (Fe3+–TPTZ) complex and producing a
colored ferrous tripyridyltriazine (Fe2+–TPTZ). RGSE had
FRAP value of 114.24 ± 0.03 mM FeSO4/g dried extract.
The hydroxyl radical is one of representative reactive oxy-
gen species generated in the body. The results showed
that the IC50 values of RGSE and trolox were 5.40 ± 0.01
and 2.16 ± 0.06 mg/ml, respectively. In addition, RGSE
had a scavenging activity on the superoxide radicals in
a concentration-dependent manner with the IC50 value
of 0.58 ± 0.01 mg/ml, while the IC50 value of trolox was
found to be 0.32 ± 0.01 mg/ml. The results indicated that
RGSE had 1.81-times less potency than trolox. In addition,
RGSE were assayed for its Fe2+ chelating power, and this
activity was compared with the chelating activity of the
synthetic metal chelator EDTA. The results showed that
RGSE had the FICP value of 3,474.05 ± 5.55 mg EDTA/g
dried extract.
The effects of RGSE on AGEs formation
As shown in Figure 1, the formation of AGEs was moni-
tored weekly by measuring fluorescence intensity of
the BSA-fructose solutions. When BSA was incubated
with fructose, the significant increase in fluorescence
intensity was observed during 4 weeks of the experiment.cavenging activity, TEAC, FRAP, HRSA, SRSA, and FICP
Antioxidant activity
HRSA SRSA FICP
± 0.03 5.40 ± 0.01 0.58 ± 0.01 3,474.05 ± 5.55
- - -
2.16 ± 0.06 0.32 ± 0.01 -
yl radical scavenging activity (HRSA), and Superoxide radical scavenging
pressed as mg trolox/gram dried extract, mM FeSO4/gram dried extract, and
Figure 1 The effects of red grape skin extract (RGSE) on formation of fluorescent advanced glycation end products (AGEs) in BSA
incubated with fructose. Each value represents the mean ± SE (n = 3). ap < 0.05 when compared to BSA/fructose at week 1; bp < 0.05 when
compared to BSA/fructose at week 2; cp < 0.05 when compared to BSA/fructose at week 3; dp < 0.05 when compared to BSA/fructose at week 4.
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BSA/fructose system, the fluorescence intensity was signifi-
cantly decreased in a concentration-dependent manner
throughout the study period. At week 4 of incubation, the
percentage inhibition of AGEs formation by RGSE (0.031–
0.500 mg/ml) was 55.23% to 63.52%, respectively. A signifi-
cant inhibition of AGEs formation (73.3%) was observed in
fructose-induced glycated BSA plus AG (0.5 mg/ml).
The effects of RGSE on the level of fructosamine
The effects of RGSE on the level of fructosamine are
shown in Table 2. The level of fructosamine in BSA/
fructose increased markedly throughout the 4 weeks
of the experiment. In contrast, the addition of RGSE to-
gether with BSA/fructose significantly suppressed the gen-
eration of fructosamine at weeks 1 to 4. At the end of
study, RGSE at the concentration of 0.062–0.500 mg/ml
significantly reduced the level of fructosamine, by approxi-
mately 4.0%–10.5%., whereas AG (0.500 mg/ml) decreased
the level of fructosamine by 15.4%.Table 2 The effects of RGSE on the level of fructosamine in B
Experimental groups
Week 1
BSA/fructose 1.69 ± 0.03
BSA/fructose/RGSE (0.031 mg/ml) 1.57 ± 0.02
BSA/fructose/RGSE (0.062 mg/ml) 1.46 ± 0.05a
BSA/fructose/RGSE (0.125 mg/ml) 1.48 ± 0.01a
BSA/fructose/RGSE (0.250 mg/ml) 1.44 ± 0.02a
BSA/fructose/RGSE (0.500 mg/ml) 1.35 ± 0.05a
BSA/fructose/AG (0.500 mg/ml) 1.31 ± 0.02a
Results are expressed as mean ± SEM (n = 3). ap < 0.05 when compared to BSA/fruct
when compared to BSA/fructose at week 3; dp < 0.05 when compared to BSA/fructoThe effects of RGSE on protein oxidation
The determination of carbonyl content and thiol groups
was used in order to assess the protein oxidation that oc-
curred during the process of glycation. As shown in Table 3,
the carbonyl content of glycated BSA was significantly
increased during the experimental period, whereas BSA/
fructose incubated with RGSE (0.062–0.500 mg/ml) signifi-
cantly attenuated an increase in protein carbonyl content
of BSA. At week 4, compared to BSA/fructose, the percent-
age reduction of carbonyl content by RGSE at concentra-
tion of 0.062–0.500 mg/ml was 37.7% to 41.7%, whereas
that by AG was 45.1%.
The effects of RGSE on the oxidation of protein thiols
are shown in Table 4. When BSA was incubated with
fructose, the level of thiol groups had continuously de-
creased throughout the experimental period. When
comparing with BSA/fructose at week 1, BSA/fructose
had a 70.1% reduction in the level of thiol groups at week
4. In the meantime, there was a significant improvement
in the level of thiol groups after addition of RGSESA/fructose system
Fructosamine (mM)
Week 2 Week 3 Week 4
2.05 ± 0.04a 2.30 ± 0.05a 2.47 ± 0.06a
1.99 ± 0.05 2.11 ± 0.06c 2.40 ± 0.08
1.85 ± 0.02b 2.00 ± 0.04c 2.37 ± 0.01d
1.69 ± 0.05b 2.09 ± 0.03c 2.35 ± 0.03d
1.69 ± 0.09b 2.05 ± 0.04c 2.28 ± 0.07d
1.66 ± 0.04b 2.00 ± 0.06c 2.21 ± 0.04d
1.60 ± 0.06b 2.09 ± 0.02c 2.09 ± 0.06d
ose at week 1; bp < 0.05 when compared to BSA/fructose at week 2; cp < 0.05
se at week 4.
Table 3 The effects of RGSE on carbonyl content in BSA/fructose system
Experimental groups Protein carbonyl content (nmol/mg protein)
Week 1 Week 2 Week 3 Week 4
BSA/fructose 1.49 ± 0.54 2.56 ± 0.06a 3.48 ± 0.05a 4.44 ± 0.06a
BSA/fructose/RGSE (0.031 mg/ml) 1.21 ± 0.02a 1.78 ± 0.06b 2.42 ± 0.01c 2.92 ± 0.02d
BSA/fructose/RGSE (0.062 mg/ml) 1.26 ± 0.04a 1.79 ± 0.06b 2.41 ± 0.02c 2.76 ± 0.05d
BSA/fructose/RGSE (0.125 mg/ml) 1.13 ± 0.03a 1.59 ± 0.02b 2.28 ± 0.03c 2.76 ± 0.05d
BSA/fructose/RGSE (0.250 mg/ml) 1.07 ± 0.03a 1.49 ± 0.07b 2.34 ± 0.02c 2.72 ± 0.02d
BSA/fructose/RGSE (0.500 mg/ml) 0.99 ± 0.01a 1.45 ± 0.02b 2.24 ± 0.04c 2.59 ± 0.02d
BSA/fructose/AG (0.500 mg/ml) 0.87 ± 0.01a 1.73 ± 0.04b 2.05 ± 0.03c 2.31 ± 0.02d
Results are expressed as mean ± SEM (n = 3). ap < 0.05 when compared to BSA/fructose at week 1; bp < 0.05 when compared to BSA/fructose at week 2; cp < 0.05
when compared to BSA/fructose at week 3; dp < 0.05 when compared to BSA/fructose at week 4.
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findings showed that the percentage improvement of thiol
groups by RGSE was between 27.6% and 50.4%, whereas
AG significantly prevented (57.9%) the depletion of protein
thiol groups.
The effect of RGSE on CML formation
CML has been used as a biomarker for the formation of
non-fluorescent AGE. As shown in Figure 2, the RGSE
(0.250 and 0.500 mg/ml) decreased 41.7% and 58.1% of
CML formation when compared to BSA/fructose. In the
group of AG (0.500 mg/ml), the formation of CML was
decreased by 72.5%, as compared to BSA/fructose.
Discussion
The glycation process causes various types of protein
and chemical modifications, resulting in the generation
of irreversible heterogeneous byproducts termed advanced
glycation end products (AGEs). The accumulation of AGEs
plays a primary role in the aging process as well as the
pathogenesis of age-related disorders including Alzheimer’s
disease and diabetic complications [25,26]. In recent de-
cades, over consumption of high-fructose diets has dramat-
ically increased and has been linked to an increase in
obesity and diabetic complications. Nowadays, there hasTable 4 The effects of RGSE on the level of thiol group in BSA
Experimental groups
Week 1
BSA/fructose 2.31 ± 0.06
BSA/fructose/RGSE (0.031 mg/ml) 2.29 ± 0.08
BSA/fructose/RGSE (0.062 mg/ml) 2.33 ± 0.09
BSA/fructose/RGSE (0.125 mg/ml) 2.51 ± 0.07a
BSA/fructose/RGSE (0.250 mg/ml) 2.41 ± 0.13a
BSA/fructose/RGSE (0.500 mg/ml) 2.60 ± 0.10a
BSA/fructose/AG (0.500 mg/ml) 2.51 ± 0.09a
Results are expressed as mean ± SEM (n = 3). ap < 0.05 when compared to BSA/fruct
when compared to BSA/fructose at week 3; dp < 0.05 when compared to BSA/fructobeen much concern regarding the important role of dietary
fructose in the development of metabolic diseases. In the
context of intracellular glycation, the rate for fructose is
faster than that of glucose [27,28]. Because of the faster
rate of the reactive glycolytic intermediates in the forma-
tion of AGEs, fructose and its metabolites are believed to
be important precursors in the intracellular formation of
AGEs. In the early stage of glycation, unstable Schiff ’s
bases are formed and turned into Amadori products such
as fructosamine, which is clinically used as an indicator
for short term control of blood sugar in diabetic patients
[29]. The reduction of fructosamine, therefore, is a thera-
peutic way to delay incident vascular complications [30].
In addition, the production of Nε-(carboxymethyl)lysine
(CML) is one of the best characterized compounds of ad-
vanced glycation end products which are generated either
from oxidative breakdown of Amadori products or polyol
pathway mediated by α-oxoaldehydes such as glyoxal,
methylglyoxal, and 3-deoxyglucosone [31]. Aside from
the formation of AGEs, reactive carbonyl intermediar-
ies and protein carbonyl derivatives also cause protein
modifications that are particularly prone to oxidative
reaction to amino acid such a cysteine. The reactive oxygen
species are generated during glycation and glyoxidation
and are able to oxidize side chains of amino acid/fructose system
Thiol group (nmol/mg protein)
Week 2 Week 3 Week 4
1.71 ± 0.10a 1.12 ± 0.10a 0.69 ± 0.14a
2.04 ± 0.09b 1.57 ± 0.09c 0.83 ± 0.17
2.15 ± 0.11b 1.61 ± 0.11c 0.88 ± 0.08d
2.16 ± 0.06b 1.53 ± 0.07c 0.97 ± 0.15d
2.26 ± 0.08b 1.56 ± 0.08c 0.94 ± 0.07d
2.37 ± 0.10b 1.63 ± 0.10c 1.04 ± 0.12d
2.35 ± 0.07b 1.59 ±0.09c 1.09 ± 0.09d
ose at week 1; bp < 0.05 when compared to BSA/fructose at week 2; cp < 0.05
se at week 4.
Figure 2 The effects of red grape skin extract (RGSE) on the level of Nε-(carboxymethyl) lysine (CML) in BSA incubated with fructose
after 4 weeks of incubation. Each value represents the mean ± SEM (n = 3). bp < 0.05 compared to BSA/ Fructose.
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also diminish an oxidative defense of protein by de-
creasing thiol groups [32,33]. Thus, these phenomena are
reflective of high oxidative stress, protein oxidative dam-
age, and formation of AGEs, which is the direct reflection
of excess of free radical generation.
Based on the fluorescence property, we studied the in-
fluence of RGSE on the formation of total AGEs. Our re-
sults demonstrated that RGSE efficiently inhibited AGEs
formation. Furthermore, RGSE also reduced the level of
fructosamine and the formation of Nε-(carboxymethyl)
lysine (CML) associated with decreased formation of
AGEs. Consequently, significant elevation of protein
carbonyl content and oxidation of thiols in BSA were
observed when the protein was glycated by fructose. In
contrast, when RGSE was added to the same systems, it
significantly suppressed these processes. Several biochem-
ical mechanisms of anti-glycation reactions have recently
been proposed [3]. During the early stage of glycation,
Schiff bases are prone to oxidation, generating free radi-
cals, reactive carbonyl groups and the formed AGEs. Scav-
enging hydroxyl radicals and superoxide radicals can
alleviate oxidative stress and reduce the generation of
reactive carbonyl compounds [3]. In addition, transition
metal also catalyzes auto-oxidation of glucose and further
generates reactive carbonyl compounds to form AGEs.Thus, metal chelators may retard the process of AGEs by
preventing further oxidation of Amadori products and
metal-catalyzed glucose oxidation [34].
It has been reported that many antioxidant-containing
foods can scavenge free-radicals generated during the
glycation process as well as prevent reducing sugars and
Amadori products from self-oxidation, leading to the in-
hibition of AGE formation [35]. In the present study,
various methods of accessing antioxidant capacities have
been used for RGSE. DPPH is widely used to evaluate
the free radical scavenging abilities of phytochemical com-
pounds in vitro. FRAP assay has been used extensively to
evaluate the ability of edible plants to reduce ferric ions,
reflecting their ability to decrease reactive oxygen species
(ROS) [36]. TEAC assay has been used for assessing the
capacity of edible plants to scavenge ABTS radicals [37].
The HRSA and SRSA have been applied to investigate the
abilities of antioxidants to scavenge hydroxyl and super-
oxide radicals [38]. From the results obtained in the
present study, RGSE showed potent antioxidant properties.
According to the abovementioned antiglycation mecha-
nisms, RGSE may inhibit AGE formation by decreasing the
ROS formation or by scavenging the ROS formed in vitro
by auto-oxidation of sugars and/or oxidative degradation
of Amadori products. However, the antioxidant activity of
RGSE might not be the only reason for explanation
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antiglycation have been proposed, such as breaking the
cross-linking structures in the formed AGEs and inhibiting
the formation of late-stage Amadori products. Further
comprehensive studies of RGSE are required to evaluate
the antiglycation mechanisms described above.
Phenolic compounds, flavonoids and anthocyanins are
constituents of many edible plants, and they are of current
research interest because of their health-promoting effect
as antioxidants. The phytochemical analysis of red grape
skin reveals the presence of phenolic compounds such
as proanthocyanidins, ellagic acid, myricetin, quercetin,
rutin, kaempferol, trans-resveratrol, cyanidin-3-glucoside,
delphinidin-3-O-glucoside (myrtillin), petunidin-3-O-
glucoside, peonidin-3-O-glucoside, malvidin-3-O-glucoside
[39,40]. Furthermore, grape seeds are a rich source of poly-
phenols, which are characterized by a variety of properties,
such as antibacterial and antioxidant activities [41,42]. Sig-
nificant variations in the levels of total phenolic com-
pounds, flavonoids, and anthocyanins in skins and seeds
from different varieties of red grapes have previously been
reported [41-43]. Among 21 different cultivars, there are
45 anthocyanins, 28 flavonols, 8 flavan-3-ols, 9 cinnamic
acids, 5 benzoic acids, 5 ellagic acids and 2 stilbenes
detected in all grape skins [41].
The phenolic compounds, flavonoids and anthocya-
nins exhibit considerable free radical scavenging activ-
ities and metal ion chelating properties [44-46]. Most
antiglycation agents from the edible plants have been
reported to possess phenolic compounds and flavonoids
[47-49]. It has been reported that inhibitory activity of
flavonoids against protein glycation was strongly related
to their scavenging effect on free radicals derived from
the glycoxidation process [50]. Our findings indicate that
RGSE has high phenolic compounds, flavonoids and
anthocyanin content. According to the abovementioned
studies, it can be assumed that phenolic compounds
and flavonoids in the RGSE may contribute to the anti-
oxidant activity and antiglycation.
Conclusion
In conclusion, RGSE has potent inhibitory effects on
protein glycation and oxidation-dependent damages to
BSA. Furthermore, the results suggest that RGSE acts as
an antioxidant with suppressing effect on the formation
of AGEs. The findings may lead to the possibility of
using RGSE for preventing AGE-mediated diabetic
complications.
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